Error: Could not add to watchlist. X
+ Watchlist

Credit Suisse Lux Global Biotech Innovators Equity Fund

CSEBEBU:LX
1,396.52
USD
11.57
0.84%
As of 10/16/2017
Fund Type
SICAV
52Wk Range
969.22 - 1,404.44
1 Yr Return
34.56%
YTD Return
33.50%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
1,384.95
52Wk Range
969.22 - 1,404.44
1 Yr Return
31.05%
YTD Return
33.50%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 10/16/2017)
1,396.52
Total Assets (m USD) (on 10/16/2017)
177.000
Inception Date
03/17/2014
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
THOMAS AMREIN
Front Load Fee
3.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.90%
Expense Ratio
1.14%
Profile
Credit Suisse Lux Global Biotech Innovators Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
Address
Credit Suisse AG
Kalanderplatz 1
8070 Zurich
Switzerland
Tel: +41 44 333 40 50
Phone
-